|
Corporate Sponsor
|
|
|
|
|
|
Sector in Focus: Biotech
Stocks
|
|
 WSNC
Online Biotech Investor Forum
Investor
Presentations from Today's Leaders in the Biotechnology Sector. WSNC,
in conjunction with Ludlow BioVentures brings you executive presentations from today's leaders in
the biotechnology sector as we get the latest in breaking
technology, recent phase study results, and commercial prospects
going forward.
Register
to Biotech Investor Newsletter
|
|
|
| Featured
Biotechnology Executives |
|
Dr. Rahul Singhvi
Pres & CEO
Novavax, Inc
(NASD:NVAX)
|
|
Dr. Burton Feinerman
Chairman CEO
Stem Cell GeneNano
(Private)
|
|
John V. Cappello
Chairman CEO
Emergent Health Corp
(OTC:EMGE)
|
|
Peter Berry
Director
Cryoport, Inc
(OTC:CYRX)
|
|
|
|
Presentation
Request
Schedule presentation slot for our online biotech investment forum
|
Biotech
Investor Newsletter
Register to our free biotech investor newsletter and network
|
|
Investor
Presentations
|
|
|
Novavax, Inc. (NASD: NVAX)
Novavax,
Inc., a clinical-stage biopharmaceutical company, focuses on
developing vaccines using its virus-like particle platform
technology for infectious diseases. It develops vaccines against the
H5N1 and other subtypes of avian influenza with pandemic potential,
human seasonal influenza, and Respiratory Syncytial Virus, as well
as Varicella Zoster that causes shingles. www.novavax.com
Shares Outstanding:
86 million
Sector: Influenza
Vaccine, Swine Flu
 Dr.
Rahul Singhvi, CEO of Novavax Discusses Influenza Vaccine
 Research
Opinion on Novavax
|
|
Stem Cell Gene Nano, Inc. (Private)
Based
in Tampa, FL, Stem Cell GeneNano, Inc. has been treating patients for
the last four years for such serious chronic diseases including ALS,
Alzheimer's, Parkinsonism, multiple sclerosis, autism, post stroke,
brain damage, diabetes, heart disease, advanced kidney disease, COPD,
scleroderma, lupus, rheumatoid arthritis, Crohn's, advanced cancer,
transverse myeltis, etc. www.stemcellgenenano.com
Shares Outstanding:
18 million
Sector: Stem Cell
Treatments
Dr.
Burton Feinerman Discusses Stem Cell Treatments
Research Opinion
on Stem Cell Gene Nano, Inc.
|
|
Emergent Health Corp (OTC:
EMGE)
Emergent
is focusing current efforts on marketing licensed patent pending
natural stem cell propagating agents capable of enhancing each
individual's ability to increase their own adult stem cells from
their bone marrow and under a patent pending application to market a
dual acting all natural diet aid designed to help control hunger
through normal body signals to the brain and stomach. Emergent was
founded in 2006 and is now headquartered in King of Prussia, PA. www.emergenthealth.com
Shares Outstanding:
19.8 million
Sector: Health
& Wellness
Emergent
Health Corp. - Investor Presentation
Research
Opinion on Emergent Health Corp
|
|
Girus Life Sciences (Private) - is a cell biology-based company
dedicated to developing technologies that control biological
outcomes in tissues and in tissue culture.
Listen
to Investor Presentation
|
|
Tunitas Therapeutics (Private) - is a privately held
biopharmaceutical company that is poised to develop unique and
precisely targeted protein therapeutics that will dramatically
change the lives of allergy sufferers.
Listen
to Investor Presentation
|
|
Myelogix (Private) - .
Listen
to Investor Presentation
|
|
Cryoport, Inc. (OTC: CYRX) - develops leading edge,
proprietary, technology-driven shipping and storage products for use
in the rapidly growing global biotechnology and biopharmaceutical
cold shipping chain.
Listen
to Investor Presentations (coming soon)
|
|
BioForce Nanosciences (OTC: BFNH) - creates products and
solutions for the life sciences by integrating biological and
mechanical systems at the micro and nano scales.
- Transcript of Investor Presentations (coming soon)
|
|
Nile Therapeutics (NASD: NLTX) - is a clinical-stage
biopharmaceutical company that develops innovative products for the
treatment of cardiovascular disease and other areas of unmet medical
need.
Listen
to Investor Presentations (coming soon)
|
|
|
|
----------------
For More Information:
Wall Street Newscast
Email: info@wallstreetnewscast.com
|
|
|
